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Abstract
Introduction Dopexamine may be a therapeutic option to
improve hepatosplanchnic perfusion in sepsis. To investigate
this possibility, we administered dopexamine in an experimental
sepsis model in rats.
Methods This prospective, randomized, controlled laboratory
study was conducted in 42 Wistar rats. The animals were
divided into three groups. Group 1 served as the control group
(CON group). The animals in both groups 2 (LPS group) and 3
(DPX group) received an endotoxin (lipopolysaccharide from
Escherichia coli – LPS) infusion (20 mg/kg for 15 minutes).
DPX group additionally received dopexamine (0.5 µg/kg per
minute over four hours). One half of the animals in each group
underwent studies of intestinal microvascular blood flow (IMBF)
using laser Doppler fluxmetry. In the other half an intravital
microscopic evaluation of leucocyte-endothelial cell interaction
in intestinal microcirculation was conducted. Functional capillary
density (FCD) in the intestinal mucosa and in the circular as well
as longitudinal muscle layer was estimated.
Results One hour after endotoxin challenge, IMBF decreased
significantly in LPS group to 51% compared with baseline (P <
0.05). In DPX group (endotoxin plus dopexamine) we found
IMBF values significantly higher than those in LPS group
(approximately at the level of controls). The impaired FCD
following endotoxin challenge was improved by dopexamine in
the longitudinal muscle layer (+33% in DPX group versus LPS
group; P < 0.05) and in the circular muscle layer (+48% in DPX
group versus LPS group; P < 0.05). In DPX group, dopexamine
administration reduced the number of firmly adherent leucocytes
(-31% versus LPS group; P < 0.05). Plasma levels of tumour
necrosis factor-α were reduced by dopexamine infusion (LPS
group: 3637 ± 553 pg/ml; DPX group: 1933 ± 201 pg/ml) one
hour after endotoxin challenge.
Conclusion Dopexamine administration improved IMBF and
FCD (markers of intestinal microcirculation) and reduced
leucocyte activation (a marker of inflammation) in experimental
sepsis.
Introduction
Sepsis and septic shock represent the most frequent causes
of death in surgical intensive care units. Despite an abundance
of experimental and clinical studies of sepsis, the mortality rate
(40–70%) has remained unchanged over recent years.
Deterioration in hepatosplanchnic perfusion plays a pivotal
role in the pathogenesis of sepsis and multisystem organ fail-
ure [1,2]. Intestinal hypoperfusion results in a disturbance in
mucosal microcirculation, gut barrier dysfunction with
increased intestinal permeability, and resulting invasion of bac-
teria and their toxins into the systemic circulation. Leucocyte-
endothelium interactions and cytokine release are signs of the
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inflammatory reaction [3]. Because of the involvement of
impaired hepatosplanchnic perfusion in the pathogenesis of
sepsis, maintenance of hepatosplanchnic perfusion is a focus
of experimental and clinical sepsis research.
The standard supportive treatment for sepsis consists of ven-
tilatory support, adequate volume resuscitation and applica-
tion of vasoactive drugs, with the aim being to maintain
adequate oxygen delivery to all organs and to the gut in partic-
ular. In addition to noradrenaline (norepinephrine), adrenaline
(epinephrine), dopamine and dobutamine, dopexamine has
been the subject to various investigations [4-6]. Over recent
years the influence of synthetic catecholamines – primarily
dopexamine – on gastrointestinal microcirculation has come
to the fore [7-10]; and what is more, dopexamine also appars
to have anti-inflammatory effects [11].
To test the hypothesis that administration of dopexamine can
improve parameters of hepatosplanchnic perfusion in experi-
mental endotoxaemia, we used intestinal laser Doppler fluxm-
etry (LDF) and intravital fluorescence microscopy (IVM). We
evaluated the effects of dopexamine on intestinal microvascu-
lar blood flow (IMBF; estimated using LDF), on intestinal func-
tional capillary density (FCD), and on leukocyte-venular




We obtained 42 male Wistar rats (weight 200–250 g, age 6–
8 weeks) from Tierzucht Schönwalde GmbH (Schönwalde,
Germany). They were housed in chip-bedded cages in air-con-
ditioned animal quarters, and were acclimatized to the institu-
tional animal care unit for one week before the experiments
were conducted. The animals were maintained on a 12-hour
light/dark cycle and were given free access to water (drinking
bottle) and standard rat chow (Altromin®; Altromin, Lage, Ger-
many). Food was withdrawn 18 hours before each experiment,
whereas water remained freely accessible. Animal experi-
ments were approved by our institutional review board for the
care of animals and were performed in accordance with Ger-
man legislation on protection of animals.
Anaesthesia and monitoring
The animals were initially anaesthetized with 60 mg/kg pento-
barbital (Sigma, Deisenhofen, Germany) intraperitoneally and
were supplemented with 20 mg/kg per hour pentobarbital
intravenously during the experiment. The animals were fixed in
supine position on a heating pad, maintaining a rectal temper-
ature between 36.5°C (97.7°F) and 37°C (98.6°F). Tracheos-
tomy was performed to maintain airway patency, and the
animals breathed room air spontaneously. The left jugular vein
and carotid artery were cannulated with polyethylene cathe-
ters (PE50; inner diameter 0.58 mm; outer diameter 0.96 mm;
Portex, Hythe, Kent, UK). The arterial pressure and heart rate
were recorded continuously (Biomonitor BMT 5231; RFT,
Staßfurt, Germany). The animals received 7.5 ml/kg per hour
crystalloid solution (Thomaejonin®; Thomae, Biberach,
Germany).
General protocol
The experiments started 30 minutes after cannulation (base-
line; time point 0 h). The rats were divided into three groups of
14 animals each. Animals in group 1 did not receive endotoxin
and served as controls (CON group). In groups 2 (LPS group)
and 3 (DPX group) endotoxaemia was induced by continuous
infusion of 20 mg/kg lipopolysaccharide (LPS) from
Escherichia coli, serotype O55:B5 (Sigma) over 15 minutes.
The animals in CON group were administered an equivalent
amount of normal saline. Then, animals in DPX group were
also administered 0.5 µg/kg per minute dopexamine (Dopac-
ard®; Elan Pharma, Munich, Germany) over the four-hour
period of observation, which began after completion of the
endotoxin infusion. Animals in CON group and in LPS group
were given an equivalent amount of normal saline.
In one half of the animals of each group, LDF was performed.
The other half of the animals underwent examination of leuco-
cyte adherence on submucosal venular endothelium by IVM of
the small bowel wall; they also underwent evaluation of FCD in
the intestinal mucosa and the circular as well as longitudinal
muscle layers. Measurements of IMBF by LDF were performed
at 0, 1, 2 and 4 hours after the start of the experiment. IVM was
performed after two hours. Laparotomy for IVM was performed
before the start of the endotoxin or placebo infusion. The
abdomen was opened by a midline incision. A section of the
distal small intestine (10 mm orally from the ileocaecal valve)
was placed carefully on a specially designed stage attached to
the microscope. During the entire in vivo microscopic proce-
dure, intestine was superfused with thermostatically controlled
(37°C [98.6°F]) crystalloid solution (Thomaejonin®) in order to
avoid drying and exposure to ambient air [12]. At the end of the
experiments, the animals were euthanized by pentobarbital
overdose.
Laser Doppler fluxmetry
The glass fibre laser Doppler probe (diameter 120 µm, wave
length 810 nm, resulting penetration depth about 1–2 mm
[13]) was calibrated using a calibration solution (Lawrenz
GmbH, Sulzbach, Germany) and attached to a distal ileal seg-
ment with enbucrilate (Histoacryl®; Braun, Melsungen, Ger-
many) without any compression or traction of the gut. Pilot
experiments have demonstrated that low dosages of enbucri-
late do not influence intestinal blood flow or intestinal function.
The position of the probe was not altered during the course of
the experiment. The intestine was neither touched nor moved.
A transparent plastic cover was placed over the preparation,
which was kept moist throughout the experiment with temper-
ature controlled Ringer's solution (37°C). The probe wasAvailable online http://ccforum.com/content/10/4/R117
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connected to a laser blood flow monitor (MBF3D; Moor Instru-
ments, Axminster, UK).
The flux values were calculated after measuring the speed and
concentration of the moving red blood cells. The speed was
estimated according to the magnitude of the laser Doppler fre-
quency shift, whereas concentration was taken from the total
power of the photodetector current. Laser Doppler flux signals
were analogue-to-digital (AD) converted and recorded using a
personal computer-based system for four minutes, with a sam-
pling rate of 40 Hz. The laser Doppler flux signal was low pass
filtered by the MBF3D with a corner frequency of 0.1 Hz
before AD conversion in order to avoid aliasing effects at a
sampling rate of 40 Hz. The region for measurements was
selected by visual control. Regions with larger vessels or per-
istalsis were avoided. At chosen regions, 100 perfusion units
were aspired. Offline, stationarity of the signal was verified by
visual inspection of the time series (minimal period 3.5
minutes).
Intravital microscopy
The intravital fluorescence videomicroscopy was performed by
using an epifluorescent microscope (Axiotech Vario, filter
block No. 20; Zeiss, Germany) with a 50-W HBO (Osram,
Munich, Germany) short arc mercury lamp and equipped with
a 10× long distance (10/0.5; Fluar, Zeiss, Oberkochen, Ger-
many) and a 20× water immersion (20/0.5; Achroplan, Zeiss)
objective (mesentery: 40× water immersion, 40/0.8; Achrop-
lan, Zeiss) and a 10× eyepiece. The images were transferred
to a monitor (LDH 2106/00; Philips Electronics, Eindhoven,
The Netherlands) with the help of a video camera (FK 6990-
IQ; Pieper, Schwerte, Germany) and were recorded at the
same time on a videotape using a video casette recorder (Pan-
asonic AG 6200; Matsushita, Osaka, Japan) for offline
evaluation.
The leucocytes were stained in vivo by intravenous injection of
0.2 ml of 0.017 g % rhodamine 6G (MW 479; Sigma, Deisen-
hofen, Germany) for contrast enhancement, enabling visualiza-
tion in the microvasculature. The microvessels in the intestinal
submucosal layer were classified by their order of branching,
in accordance with the classification proposed by Gore and
Bohlen [14]. Submucosal collecting venules (V1) as well as
postcapillary venules (V3) were analyzed. Activated leuco-
cytes, adhering firmly to the venular endothelium, were defined
in each vessel segment as cells that did not move or detach
from the endothelial lining within an observation period of 30
s. They are indicated as number of cells per square millimetre
of endothelial surface, calculated from diameter and length of
the vessel segment studied, assuming cylindrical geometry.
Seven vessels of each population were evaluated in every ani-
mal. The evaluation of leucocyte adherence was performed in
a blinded manner.
After two hours of endotoxaemia, 50 mg/kg body weight FITC-
labeled bovine serum albumen (Sigma) was administered
intravenously to distinguish plasma from red blood cells (neg-
ative contrast). The assessment of FCD in the intestinal
mucosa and the circular as well as longitudinal muscle layers
was performed by morphometric determination of the length of
red blood cell perfused capillaries per area, in accordance
with the method proposed by Schmid-Schönbein and col-
leagues [15]. Five separate fields were examined in each layer.
Tumour necrosis factor-α
At baseline (0 hours) and after 1, 2 and 4 hours, 200 µl
heparinized arterial blood samples were drawn for estimation
of plsma levels of tumour necrosis factor (TNF)-α. For analysis
we used a rat-specific solid-phase enzyme-linked immuno-
sorbent assay kit (Genzyme Corp., Cambridge, MA, USA)
employing the multiple antibody sandwich principle in accord-
ance with the manufactorer's instructions. A microtitre plate,
pre-coated with monoclonal anti-TNF-α, was used to capture
Table 1
Heart rate and mean arterial pressure findings
Group Time (hours)
0 0 . 5 1234
Heart rate (beats/minute) CON 335 ± 18 347 ± 20 351 ± 20 349 ± 21 343 ± 19 339 ± 9*†
LPS 342 ± 11 347 ± 12 365 ± 17 387 ± 11‡ 378 ± 11‡ 390 ± 9‡
DPX 321 ± 9 366 ± 9 399 ± 7§ 394 ± 8§ 384 ± 15§ 394 ± 12§
Mean arterial pressure 
(mmHg)
CON 120 ± 5 119 ± 8*† 109 ± 7* 107 ± 8 116 ± 3 118 ± 5*
LPS 116 ± 3 74 ± 2‡ 87 ± 3‡ 94 ± 4‡ 88 ± 3‡ 89 ± 5‡
DPX 120 ± 6 70 ± 2§ 107 ± 7§ 102 ± 7§ 104 ± 8§ 99 ± 9§
CON, control group; DPX, DPX group (endotoxin plus dopexamine); LPS, LPS group (endotoxin infusion only). *P < 0.05 CON versus LPS; †P < 
0.05 CON versus DPX; ‡P < 0.05 LPS versus LPS at baseline; §P < 0.05 DPX versus DPX at baseline.Critical Care    Vol 10 No 4    Birnbaum et al.
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rat TNF-α from test samples. Unbound material was removed
by washing with buffer solution. A peroxidase-conjugated pol-
yclonal anti-TNF-α antibody, which binds to captured rat TNF-
α, was added. By addition of substrate solution, a peroxidase
catalyzed colour change proceeds and the absorbence meas-
ured at 450 nm is proportional to the concentration of rat TNF-
α in the sample. A standard curve was obtained by plotting the
concentrations of rat TNF-α standards versus their absorb-
ences. The TNF-α concentration of the samples was deter-
mined using this standard curve. Intra-assay reproducibility is
indicated by the following coefficients of variation: at rat TNF-
α mass 1,024.4 pg/ml the coefficient was 6.6, and at rat TNF-
α mass of 376.5 pg/ml it was 3.7. The inter-assay reproduci-
bility is indicated by the following coefficients of variation: at
rat TNF-α mass 766.4 pg/ml the coefficient was 3.8, and at a
rat TNF-α mass of 168.3 pg/ml it was 6.5.
Statistical analysis
The data analysis was performed by means of a statistical soft-
ware package (SigmaStat; Jandel Scientific, Erkrath, Ger-
many). All data were expressed as group mean ± standard
error of the mean. After establishing that the data conformed
with tests of normality of distribution and equality of variance,
they were analyzed using one-way analysis of variance fol-
lowed by Scheffé's test. P < 0.05 value was considered sta-
tistically significant.
Results
None of the animals died during the period of observation.
Heart rate and mean arterial pressure
In both endotoxaemic groups (LPS and DPX group), endotoxin
challenge resulted in increased heart rate and decreased
mean arterial pressure (MAP) compared with baseline and
compared with controls (Table 1). One hour after endotoxin
challenge, MAP levels in DPX group were restored to control
levels and remained at this level.
Laser Doppler fluxmetry
One hour after endotoxin challenge IMBF decreased signifi-
cantly in LPS group to 51% compared with baseline (P <
0.05; Figure 1). At two and four hours after the start of the
experiment, we also observed decreased laser Doppler flow in
LPS group compared with that in CON group. Animals in DPX
group exhibited significantly higher values compared with
those in LPS group.
Functional capillary density
The impairment in FCD due to endotoxin challenge was pre-
vented by dopexamine in the longitudinal muscle layer (+33%
in DPX group versus LPS group; P < 0.05) and was also
attenuated in the circular muscle layer (+48% in DPX group
versus LPS group; P < 0.05; Figure 2). FCD in the intestinal
mucosa was not influenced either by endotoxin challenge or
by dopexamine (data not shown).
Leucocyte-endothelium interaction
Figure 3 summarizes counts of firmly adherent leucocytes in
V1 and V3 venules of intestinal submucosa two hours after the
start of the endotoxin challenge. In V1 venules the count was
sixfold higher after endotoxin challenge in LPS group
compared with CON group (LPS group 364 ± 23 per mm2
versus CON group 62 ± 10 per mm2; P < 0.05). In V3 venules
endotoxin administration in LPS group resulted in a fivefold
increase in adherent leucocytes compared with controls (470
± 21 per mm2 versus 96 ± 14 per mm2; P < 0.05).
Figure 1
Intestinal microvascular blood flow Intestinal microvascular blood flow. Shown is intestinal microvascular blood flow (IMBF) as a percentage of baseline; measurements taken at base-
line (time point 0 hours) and at 1, 2 and 4 hours after the start of the experiment. CON, control group; DPX, DPX group (endotoxin plus dopexam-
ine); LPS, LPS group (endotoxin infusion only). *P < 0.05 versus baseline; †P < 0.05 versus CON; ‡P < 0.05 versus DPX.Available online http://ccforum.com/content/10/4/R117
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In DPX group, we found a significant reduction in endotoxin-
induced leucocyte adherence (-31%) in the V1 subpopulation
of venules relative to that in LPS group (P < 0.05). In V3
venules the reduction in leucocyte adherence (-16%) did not
achieve statistical significance. Endotoxin challenge resulted
in a decrease in leucocyte rolling to 23% compared with CON
group in V1 venules and to 12% in V3 venules (P < 0.05). This
decrease was not influenced by dopexamine administration.
Tumour necrosis factor-α
One hour after the start of endotoxin challenge, we identified
the highest TNF-α levels in LPS group (Figure 4). Dopexamine
administration significantly reduced TNF-α levels at this time
point (3,637 ± 553 pg/ml in LPS group; 1,933 ± 201 pg/ml
in DPX group).
Discussion
In the present study, the endotoxin challenge induced a dra-
matic decrease in IMBF. This is in accordance with the results
Figure 2
Functional capillary density Functional capillary density. Shown is functional capillary density (FCD) in the longitudinal and circular muscularis layers; measurements were taken 
at two hours after the start of endotoxaemia. CON, control group; DPX, DPX group (endotoxin plus dopexamine); LPS, LPS group (endotoxin infu-
sion only). *P < 0.05 versus CON; †P < 0.05 versus LPS; ‡P < 0.05 versus DPX.
Figure 3
Firmly adherent leucocyte count Firmly adherent leucocyte count. Shown are the counts of firmly adherent leucocytes (sticker) in V1 and V3 venules; measurements were taken two 
hours after endotoxin challenge. CON, control group; DPX, DPX group, (endotoxin plus dopexamine); LPS, LPS group (endotoxin infusion only). *P 
< 0.05 versus CON; †P < 0.05 versus LPS.Critical Care    Vol 10 No 4    Birnbaum et al.
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of our previous investigations in rats [16]. The administration
of dopexamine significantly increased IMBF at all measure-
ment times. Similar increases in IMBF, measured using LDF,
during dopexamine administration have been demonstrated in
other experimental and clinical settings [17-19]. In a mild
hypothermic cardiopulmonary bypass model in rabbits, dopex-
amine significantly increased jejunum and ileum blood flow,
estimated using LDF [17]. In an experimental setting in pigs,
jejunal mucosal blood flow was not influenced by dopexamine
infusion during intestinal hypotension, but dopexamine
brought about intestinal vasodilatation [10]. In postoperative
cardiosurgical patients dopexamine increased jejunal mucosal
perfusion by 20%, as measured using endoluminal LDF [7]. In
patients in septic shock, a combination of dopexamine and
noradrenaline enhanced gastric mucosal blood flow
(estimated using LDF) to an extent greater than that with
adrenaline alone, and the authors concluded that this combi-
nation could be an interesting option in the treatment of septic
shock [20]. On the other hand, dopexamine was unable to
improve gastric intramucosal partial carbon dioxide tension
[21] and could not enhance haemodynamic function and tis-
sue oxygenation [22] during major abdominal surgery.
In addition, the FCD in the longitudinal and circular muscle lay-
ers – a marker of microcirculation – was impaired in endotox-
aemic animals, as expected. Dopexamine administration led to
attenuation of this microcirculatory disturbance. However,
neither endotoxin nor dopexamine had any influence on FCD
in intestinal mucosa. At first glance, the unchanged FCD in the
intestinal mucosa appears to be contradictory to the changes
in IMBF in the intestinal wall. To understand this phenomenon,
it is important to take into consideration the fact that, because
of the laser penetration depth of about 1–2 mm, IMBF reflects
the blood flow in the whole gut wall. In contrast, FCD reflects
only the perfusion of the capillaries of the focused layer. More-
over, FCD is not diminished when blood flow in capillaries is
lower, but only when capillaries are occluded completely.
Another explanation could be a redistribution of blood flow
within the intestinal wall.
Animals of all groups received fluid resuscitation of 7.5 ml/kg
per hour crystalloid solution. After endotoxin challenge, heart
rate was increased and MAP was decreased in the endotox-
aemic groups (LPS group and DPX group; Table 1). In CON
group in particular, MAP was stable during the trial. Neverthe-
less, intravascular hypovolaemia can not be excluded and is a
typical occurrence in sepsis. The aim of this model is to induce
manifestations that are characteristic of sepsis. Because the
animals in the two endotoxaemic groups were treated in an
identical manner (with the exception of dopexamine treatment
in DPX group), the differences between the two groups of
septic animals must result from dopexamine administration.
To interpret the results of the study it is important to be aware
of some limitations of the setting. We cannot exclude an influ-
ence of hypovolaemia on the results, although this is a typical
phenomenon in sepsis. Cardiac output and global splanchnic
blood flow were not measured in the model but they could pro-
vide more data that may help in interpreting the results and
appreciating the effect of dopexamine.
In the study we found a significant reduction in activated leu-
cocytes adhering firmly to the endothelium in dopexamine-
treated endotoxaemic animals. IVM is a standard method used
Figure 4
Tumour necrosis factor-α levels Tumour necrosis factor-α levels. Shown are tumour necrosis factor (TNF)-α levels; measurements were taken one, two and four hours after induction 
of endotoxaemia. CON, control group; DPX, DPX group (endotoxin plus dopexamine); LPS, LPS group (endotoxin infusion only). *P < 0.05 versus 
baseline; †P < 0.05 versus CON; ‡P < 0.05 versus DPX.Available online http://ccforum.com/content/10/4/R117
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in in vivo studies of microcirculation [23]. Dynamic processes
such as interactions between leucocytes and endothelium, as
well as perfusion of capillaries, are visible [24]. The adherence
of leucocytes in endotoxaemia is a multistep process. After the
increase in margination of leucocytes from the centre of the
bloodstream, cells are temporarily adherent (rolling) to the
endothelium of the vessel wall [25,26]. The next step is firm
adherence of leucocytes to endothelium [27]. Activated leuco-
cytes release various mediators, including oxygen free radi-
cals, elastase, collagenase and myeloperoxidase. This leads to
an increase in endothelium permeability and to activation of
other cascade systems [28-30]. The emigration of leucocytes
represents the last step in leucocyte activation. Tissue dam-
age to vascular endothelium is one of the consequences of
leucocyte activation [31]. Decreasing or inhibiting leucocyte
adherence may be a beneficial therapeutic approach in endo-
toxaemia and sepsis.
In the present study we found a fivefold to sixfold higher count
of adherent leucocytes, depending on the size of venules, fol-
lowing endotoxin challenge compared with control animals.
The improvement in microcirculation attributable to dopexam-
ine, as indicated by the increase in LDF, appears to have an
important influence on leucocyte adherence. The adherence
also depends on shear stress in the blood flow. The restora-
tion of normal blood flow diminishes the interaction between
leucocyte and endothelium [27]. In a similar experimental
setting, dopexamine reduced leucocyte adherence in
mesenteric vessels in endotoxaemia [32]. The antioxidative
effects of dopexamine may also be responsible for the reduc-
tion in leucocyte adherence. After experimental endotoxin
challenge, production of uric acid was reduced by dopexam-
ine infusion [33]. As a result of decreased radical formation in
the xanthine oxidase pathway, this may lead to reduced leuco-
cyte-endothelium interaction.
TNF-α is an initial marker of sepsis. In experimental endotoxae-
mia it is detectable within a few minutes. Depending on the
dose of endotoxin administered, TNF-α levels increase as
soon as after 1–2 hours after endotoxin challenge [34-36].
Hence, TNF-α is a valuable indicator of sepsis induction in
experimental settings. After one hour we found peak levels of
TNF-α indicating effective induction of endotoxaemia. After
two hours TNF-α decreased to 50% of the level at one hour.
At four hours TNF-α levels were also increased compared with
baseline. The degree of TNF-α release in the present study is
comparable to the findings of others [37-39]. In the animals of
the control group we found TNF-α levels to be exclusively in
the lower range of 50 pg/ml. Thus, the inflammatory response
is not a result of preparations before the start of the experiment
(insertion of catheters, laparotomy, among other factors). The
dopexamine infusion significantly reduced the release of TNF-
α. In endotoxaemic animals treated with dopexamine we found
reductions in TNF-α release of 47% at one hour and 30% at
two hours after endotoxin challenge compared with untreated
endotoxaemic animals. In patients the increase in TNF-α levels
after cardiopulmonary bypass was attenuated by dopexamine
application [11]. Dopexamine had no effect on splanchnic
blood flow.
In our model, we performed no dose-response studies to find
out whether other doses of dopexamine were more effective.
In order to elucidate the effects of dopexamine in clinical sep-
sis, additional studies in patients are required.
Conclusion
The administration of dopexamine improved IMBF and FCD
(markers of intestinal microcirculation) and reduced leucocyte
activation (a marker of inflammation) in experimental sepsis.
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